Sugi Predict

Sugi Predict / Compounds / SCHEMBL4882935

SCHEMBL4882935

SCHEMBL4882935

CC(C)(C)OC(=O)NC(=Nc1ccc(I)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPFFR1 Q9GZQ6 3/20 0.41
▸ NPFFR2 Q9Y5X5 3/20 0.41
▸ SLC22A2 O15244 1/20 0.38
▸ SLC22A1 O15245 1/20 0.38
▸ SLC22A3 O75751 1/20 0.38
▸ MIF P14174 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ RAB9A P51151 5/20 0.35
▸ NPC1 O15118 4/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ RECQL P46063 1/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30897414 0.84 GAA (0.44) NPFFR1NPFFR2SLC22A2SLC22A1SLC22A3
SCHEMBL7043632 0.84 NPFFR1 (0.47) NPFFR1NPFFR2RAB9ANPC1SMN1; SMN2
SCHEMBL29598182 0.83 NOS3 (0.45) NPFFR1NPFFR2RECQLCA1CA2
SCHEMBL3798328 0.82 MIF (0.43) NPFFR1NPFFR2MIFRAB9ANPC1
SCHEMBL3804463 0.82 NPFFR1 (0.46) NPFFR1NPFFR2RAB9ANPC1SMN1; SMN2
SCHEMBL4889480 0.81 NOS3 (0.45) NPFFR1NPFFR2
SCHEMBL30897413 0.81 CA1 (0.42) NPFFR1NPFFR2CA1CA2
SCHEMBL30897412 0.78 CA1 (0.45) NPFFR1NPFFR2MIFRAB9ANPC1
SCHEMBL12049315 0.76 CYP17A1 (0.40) NR1H4
SCHEMBL31158185 0.76 MAPT (0.45) NPFFR1NPFFR2CA1CA2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114907241-B Guanidine compound containing fluorosulfonyl group, and preparation method and application thereof 中宏鑫投资控股(深圳)有限公司 2024-05-17 — — CN disclosed
US-8071650-B2 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea PACIFIC CORPORATION (KR) 2011-12-06 — — US disclosed
US-20080064687-A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same SUH YOUNG G 2008-03-13 — — US disclosed
US-20030153596-A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same PACIFIC CORPORATION (KR) 2003-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153596-A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same TAS2R40, TAS1R2, TAS2R45 NPFFR1 78/4885NPFFR2 110/4885SLC22A2 881/4885
US-20080064687-A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same TRPV1, TRPA1, TAS2R5 NPFFR1 100/4885NPFFR2 108/4885SLC22A2 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.